Dr. Thanos Kolyviras graduated from the Medical School of the National and Kapodistrian University of Athens (2002–2008).

Dr. Thanos Kolyviras graduated from the Medical School of the National and Kapodistrian University of Athens (2002–2008).

He completed his cardiology residency at the Université Libre de Bruxelles (2009–2013) and at the 251 Hellenic Air Force General Hospital (2013–2016), gaining comprehensive training in both clinical and interventional cardiology.

He completed his cardiology residency at the Université Libre de Bruxelles (2009–2013) and at the 251 Hellenic Air Force General Hospital (2013–2016), gaining comprehensive training in both clinical and interventional cardiology.

He completed his cardiology residency at the Université Libre de Bruxelles (2009–2013) and at the 251 Hellenic Air Force General Hospital (2013–2016), gaining comprehensive training in both clinical and interventional cardiology.

Since 2022, Dr. Kolyviras has served as Director of the 4th Cardiology Department — Interventional Cardiology Unit at Metropolitan General, where he is responsible for coordinating the catheterization laboratory and managing complex interventional cardiology cases.

From 2016 to 2021, he served as Attending Physician in the Interventional Cardiology and Valvular Heart Disease Departments at Errikos Dunant Hospital Center, actively participating in the management of coronary artery disease and structural heart disease cases.

His professional career is defined by continuous engagement with the full spectrum of interventional cardiology, within highly demanding, structured hospital environments.

Coronary Artery Disease & Angioplasty

His interventional activity encompasses the complete diagnostic and therapeutic management of coronary artery disease, including diagnostic and right heart catheterizations, coronary angiography, and coronary angioplasty.

He has extensive experience in the management of complex coronary disease, including left main disease, bifurcation lesions, multivessel disease, and chronic total occlusions (CTO).

To optimize procedural outcomes, he employs advanced imaging and plaque modification technologies, including intravascular ultrasound (IVUS), intravascular lithotripsy (Shockwave), and rotational atherectomy (Rotablator).

Advanced Techniques & High-Risk Support

For procedures of increased technical complexity, he applies specialized techniques including bioresorbable vascular scaffolds, graft angioplasty, below-the-knee peripheral interventions, and renal artery interventions.

He has experience in the use of intra-aortic balloon pump (IABP) for hemodynamic support in selected cases.

Structural Heart Disease & Specialized Interventions

His scope also includes structural heart disease interventions, such as left atrial appendage closure and atrial septal defect closure, as well as myocardial biopsies and pericardiocentesis.

He has performed specialized procedures including alcohol septal ablation for hypertrophic obstructive cardiomyopathy and retrieval of intravascular foreign bodies from the heart and great vessels.

Dr. Thanos Kolyviras actively participates in international multicenter studies in interventional cardiology, contributing to the advancement of contemporary techniques for complex coronary artery disease and transcatheter valvular interventions.

He has participated in research protocols including the Progress-CTO and HYDRA Valve studies, focusing on the optimization of revascularization in chronic total occlusions and the evaluation of new technologies in transcatheter aortic valve replacement (TAVI).

His research interests center on the improvement of hemodynamic parameters, the evaluation of novel interventional technologies, and the understanding of cardiovascular risk mechanisms.

He maintains an active international scientific profile and serves as a member of the editorial board of the Journal of Interventional Cardiology.

Dr. Thanos Kolyviras holds the title of Fellow of the European Society of Cardiology (FESC), a distinction awarded to cardiologists with documented scientific and clinical activity at a European level.

He has received the Certificate of Excellence from the European Association of Percutaneous Cardiovascular Interventions (EAPCI), as well as distinctions at Pan-European ESC Cardiology Congresses (Rome 2016 — Best Poster Award; Barcelona 2014 — Moderated Poster Presentation Winner).

He also holds certifications for transcatheter aortic valve implantation (TAVI) from international medical device manufacturers, obtained through specialized training programs.

• European Association of Percutaneous Cardiovascular Interventions (EAPCI)
• Hellenic Cardiological Society
• Working Group on Hemodynamics & Interventional Cardiology
• Working Group on Valvular Heart Disease

Interventional cardiology demands precision, scientific rigor, and accountability. Dr. Kolyviras' professional journey combines clinical experience, academic training, and continuous engagement with contemporary cardiovascular research — with the goal of delivering safe, individualized care to every patient.